Public annual accounts

DR. VERBUYST ROEL financials

Name: DR. VERBUYST ROEL financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR. VERBUYST ROEL, with comparable measures and links to available source documents.

Company overview

Registry number

0894865283

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for DR. VERBUYST ROEL

2025 versus 2024

Operating line: €272,416
EBITDA: €249,277
Total assets: €2,004,166
Equity: €1,044,086

EBITDA margin +91.5% · Equity ratio +52.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€272,416	€249,277	€2,004,166	€1,044,086	-
202431 Dec 2024	€243,617	€232,974	€2,000,579	€973,955	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report